Connect with us
Haptena Therapeutics, a biotech focused on KRAS-mutated tumors, launched operations and secured €3 million from Claris Ventures. Founded by Chiara Ambrogio and Roberto Chiarle, the company...
Salmoss Biotech, a Chilean startup, is pioneering regenerative medicine by creating bone implants from salmon-bone waste. Used in 360+ surgeries, the technology is safe, biocompatible, and...
In 2025, medical research accelerated toward precision and personalized care. Gene editing and gene therapies matured into real treatments, AI transformed diagnosis and drug discovery, and...
CAR-T therapies have transformed hematologic cancer care, achieving high remission but facing relapse, toxicity, cost, and slow manufacturing. Innovations include mRNA-based in vivo CAR-T generation for...
Chai Discovery, an OpenAI-backed biotech startup, raised $130 million in Series B funding, reaching a $1.3 billion valuation. Led by General Catalyst and Oak HC/FT, the...
Asebio welcomed the EU’s Biotech Act as a key step to boost competitiveness and health autonomy. Biotech drives jobs, growth and innovation but Europe lags globally...
Nearly one year after the EU health technology assessment regulation took effect, joint clinical assessments are underway to harmonize medicine evaluations. Spain’s AEMPS has joined as...
Johnson & Johnson’s Phase 3 MajesTEC-3 study shows that the combination of teclistamab and subcutaneous daratumumab (tec+dara) significantly improves outcomes for relapsed or refractory multiple myeloma...
EFPIA’s new report urges clearer, lifecycle-wide governance for AI in pharmaceuticals. Drawing on cross-sector insights, it calls for clarifying AI exemptions, strengthening regulator–industry dialogue, harmonizing expectations,...
Spain’s funding of new cancer drugs hinges mainly on substantial clinical benefit and quality-of-life data, while efficiency and innovation have little influence. Evidence quality speeds decisions,...